---
title: "Shanghai Junshi Biosciences Expects 2025 Revenue to Rise 28% to RMB2.5 Billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274297913.md"
description: "Shanghai Junshi Biosciences Co. Ltd. forecasts a 28% increase in revenue for 2025, estimating approximately RMB2.5 billion, up from RMB1.94 billion in 2024. This projection indicates a significant improvement in the company's business performance. The information was published via the Issuer Information Service of the Hong Kong Stock Exchange."
datetime: "2026-01-30T11:18:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274297913.md)
  - [en](https://longbridge.com/en/news/274297913.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274297913.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274297913.md) | [繁體中文](https://longbridge.com/zh-HK/news/274297913.md)


# Shanghai Junshi Biosciences Expects 2025 Revenue to Rise 28% to RMB2.5 Billion

Shanghai Junshi Biosciences Co. Ltd. has issued a preliminary results forecast for the year ending 31 December 2025. The company estimates that its operating revenue for 2025 will be approximately RMB2,500 million, representing a year-on-year increase of about RMB551.7 million or 28.32% compared to the previous year. This indicates a significant improvement in business performance for the reporting period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Junshi Biosciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260130-12006473), on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [JUNSHI BIO (01877.HK)](https://longbridge.com/en/quote/01877.HK.md)
- [Junshi Biosciences (688180.CN)](https://longbridge.com/en/quote/688180.CN.md)

## Related News & Research

- [Shanghai Junshi Biosciences Completes RMB1 Billion Technology Innovation Bond Issuance](https://longbridge.com/en/news/273700985.md)
- [MiniMax’s ARR tops USD 150 million as it pivots toward an AI platform model](https://longbridge.com/en/news/277591914.md)
- [Course Hero owner must pay university $75 million in copyright dispute, US jury says](https://longbridge.com/en/news/277968956.md)
- [Sony Takes Control of Peanuts With WildBrain Buyout](https://longbridge.com/en/news/277535810.md)
- [Fox's High Exposure to Potential NFL Rights Renewal Could Weigh on Financials, BofA Says in Downgrade](https://longbridge.com/en/news/276934658.md)